Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QUIDEL CORPORATION

(QDEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Quidel : to Market COVID-19 Home Test Kits at CVS Pharmacies, Online Next Week

09/01/2021 | 05:26pm EDT


© MT Newswires 2021
All news about QUIDEL CORPORATION
10/20QUIDEL : to Hold Fiscal Third Quarter 2021 Financial Results Conference Call on November 4..
BU
10/18QUIDEL : Pediatric Lyme Disease—‘An Epidemic Within a Pandemic!'—to be F..
BU
10/18QUIDEL : Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’â€&rdqu..
AQ
10/18PRESS RELEASE : Pediatric Lyme Disease-'An Epidemic Within a Pandemic!'-to be Focus of Fre..
DJ
10/08Occidental Petroleum, Chubb rise; Allogene, Oshkosh fall
AQ
10/07QUIDEL : ANNOUNCES PRELIMINARY REVENUE FOR FISCAL THIRD QUARTER 2021 (Form 8-K)
PU
10/07QUIDEL CORP /DE/ : Results of Operations and Financial Condition, Financial Statements and..
AQ
10/07QUIDEL : Says Preliminary Q3 Revenue to be in $505 Million to $510 Million Range
MT
10/07QUIDEL : Announces Preliminary Revenue for Fiscal Third Quarter 2021
BU
10/07Quidel Corporation Provides Revenue Guidance for the Third Quarter of 2021
CI
More news
Analyst Recommendations on QUIDEL CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 261 M - -
Net income 2021 403 M - -
Net cash 2021 536 M - -
P/E ratio 2021 14,2x
Yield 2021 -
Capitalization 5 578 M 5 578 M -
EV / Sales 2021 4,00x
EV / Sales 2022 4,59x
Nbr of Employees 1 370
Free-Float 87,8%
Chart QUIDEL CORPORATION
Duration : Period :
Quidel Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUIDEL CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 133,98 $
Average target price 151,33 $
Spread / Average Target 13,0%
EPS Revisions
Managers and Directors
Douglas C. Bryant President, Chief Executive Officer & Director
Randall J. Steward Chief Financial & Accounting Officer
Kenneth F. Buechler Chairman
Werner Kroll Senior Vice President-Research & Development
Karen C. Gibson SVP-Information Systems & Business Transformation
Sector and Competitors
1st jan.Capi. (M$)
QUIDEL CORPORATION-25.42%5 578
THERMO FISHER SCIENTIFIC30.02%239 360
DANAHER CORPORATION41.72%221 837
INTUITIVE SURGICAL, INC.24.54%121 328
SIEMENS HEALTHINEERS AG39.69%76 589
EDWARDS LIFESCIENCES CORPORATION26.71%72 144